Intervention Review

You have free access to this content

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

  1. Kana R Jat1,*,
  2. Dinesh K Walia2,
  3. Anju Khairwa3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 17 SEP 2013

Assessed as up-to-date: 11 SEP 2013

DOI: 10.1002/14651858.CD010288.pub2


How to Cite

Jat KR, Walia DK, Khairwa A. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CD010288. DOI: 10.1002/14651858.CD010288.pub2.

Author Information

  1. 1

    All India Institute of Medical Sciences, Department of Pediatrics, New Delhi, Delhi, India

  2. 2

    Govt. Medical College and Hospital (GMCH), Department of Community Medicine, Chandigarh, Chandigarh UT, India

  3. 3

    Postgraduate Institute of Medical Education and Research (PGIMER), Department of Pathology, Chandigarh, Chandigarh UT, India

*Kana R Jat, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi, 110029, India. drkanaram@gmail.com. drkanaram@yahoo.co.in.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 SEP 2013

SEARCH

  1. You have free access to this content

    Current Version

    Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

    Kana R Jat, Dinesh K Walia and Anju Khairwa

    Article first published online: 17 SEP 2013 | DOI: 10.1002/14651858.CD010288.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

    Kana R Jat, Dinesh K Walia and Anju Khairwa

    Article first published online: 12 DEC 2012 | DOI: 10.1002/14651858.CD010288